Antitrust agencies amend premerger notification rules to clarify reporting of certain acquisitions of exclusive patent rights in the pharmaceutical industry

The US Federal Trade Commission, with the concurrence of the Antitrust Division of the US Department of Justice, has amended the premerger notification rules to clarify when a transfer of exclusive rights to a patent or part of a patent in the…
By: DLA Piper